Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check3 days agoChange DetectedVersion tag updated from v3.0.1 to v3.0.2; Back to Top link removed. No substantive changes to core content.SummaryDifference0.5%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as various study status updates with specific dates. Notably, some previously listed location terms and dates have been removed.SummaryDifference53%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check47 days agoChange DetectedThe web page has been significantly updated with numerous additions related to clinical trials, including detailed information about study types, results, and regulatory bodies such as the FDA and AHRQ.SummaryDifference100%
Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.